Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Nour M. El-Etreby"'
Publikováno v:
Egyptian Journal of Medical Human Genetics, Vol 23, Iss 1, Pp 1-9 (2022)
Abstract Background Ovarian cancer (OC) is considered a leading cause of death among women with gynecological malignancies. OC, like breast cancer, shows a familial predisposition to germline mutations in genes BRCA1 or BRCA2, which have proved to pl
Externí odkaz:
https://doaj.org/article/247922d45a754f96991fdba0b6ea46b5
Publikováno v:
Journal of Ovarian Research, Vol 10, Iss 1, Pp 1-7 (2017)
Abstract Background Ovarian epithelial tumor (OET) is a silent disease of late diagnosis and poor prognosis. Currently treatment options are limited and patient response to treatment is difficult to predict so there is a serious need to delineate the
Externí odkaz:
https://doaj.org/article/f8ba1696eff74bb4bb57a20f526dc534
Publikováno v:
The Egyptian journal of immunology. 27(2)
Ovarian cancer is one of the most lethal gynecological malignancies. Mitochondria are the predominant source of reactive oxygen species (ROS) in the cell. Besides mitochondria nicotinamide adenine dinucleotide phosphate (NADPH) oxidases (NOX) enzymes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e086138d63b03c7315d07159f92b578d
https://pubmed.ncbi.nlm.nih.gov/33548975
https://pubmed.ncbi.nlm.nih.gov/33548975
Autor:
Eman M. Saied, Nour M. El-Etreby
Publikováno v:
Annals of Diagnostic Pathology. 27:62-68
Understanding different mechanisms contributing to the aggressive behaviour of epithelial ovarian cancer (EOC) is a large challenge. Interaction between inflammation, immunity and carcinogenesis occurs in different cancers; however, the potential rol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6347cbd0334b65d33128c83b40620e7f
https://doi.org/10.1016/j.anndiagpath.2017.01.006
https://doi.org/10.1016/j.anndiagpath.2017.01.006
Publikováno v:
European Journal of Gynaecological Oncology. 42:757
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::806bb16a7d6d1cc78693328f1153f0a0
https://doi.org/10.31083/j.ejgo4204114
https://doi.org/10.31083/j.ejgo4204114
Autor:
Mikel Valgañon, Maryou B. Lambros, Claudia Romano, Rachael Natrajan, Ruethairat Sriraksa, Dalal El-Kaffash, Letizia Foroni, R. Osborne, Susan Van Noorden, Pritesh Trivedi, Mona El-Bahrawy, Rania Showeil, Nour M. El-Etreby
Publikováno v:
Oncotarget
The majority of borderline ovarian tumours (BOTs) behave in a benign fashion, but some may show aggressive behavior. The reason behind this has not been elucidated. The epidermal growth factor receptor (EGFR) is known to contribute to cell survival s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f81764d579364ffbc3a6abf8f195d217
https://doi.org/10.18632/oncotarget.7257
https://doi.org/10.18632/oncotarget.7257
Autor:
Nour M. El-Etreby, Amany A. Ghazy
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 7 (2016)
Frontiers in Immunology, Vol 7 (2016)
Background Ovarian cancer is one of the most lethal gynecological malignancies and the fifth leading cause of cancer deaths among women. The high mortality rate is largely attributed to its diagnosis in advanced stages. Poor prognosis of ovarian canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4be5fb0068695c08f3c90f5c0fab8d0f
Publikováno v:
Alexandria Journal of Medicine. (4):353-360
Ovarian cancer is the most common cause of death among women with gynecologic malignancies. The standard management is maximal surgical cytoreduction followed by systemic chemotherapy. The aim of this retrospective study is to evaluate ovarian cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f4e533f2fa7c1fcffeaf2c4a19d0101